Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 423.60
Bid: 424.20
Ask: 427.20
Change: 3.00 (0.71%)
Spread: 3.00 (0.707%)
Open: 430.80
High: 432.60
Low: 422.80
Prev. Close: 420.60
CBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Special Business

18 Nov 2021 15:01

RNS Number : 8706S
Close Brothers Group PLC
18 November 2021
 

Close Brothers Group plc

Annual General Meeting resolutions passed

 

Close Brothers Group plc (the "group" or "Close Brothers") announces that at the Annual General Meeting of the group duly convened and held on Thursday 18 November 2021 at 10 Crown Place, London EC2A 4FT and electronically, the following special business resolutions of the group were passed:

 

Ordinary resolutions

 

18. To authorise the Board generally and unconditionally to allot shares in the Company and to grant rights to subscribe for or convert any security into shares in the Company:

(a) up to a nominal amount of £12,566,854 (such amount to be reduced by any allotments or grants made under paragraph (b) below in excess of such sum; and

(b) comprising equity securities (as defined in the Companies Act 2006) up to a nominal amount of £25,133,708 (such amount to be reduced by any allotments or grants made under paragraph (a) above) in connection with an offer by way of a rights issue:

(1) to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and

(2) to holders of other equity securities as required by the rights of those securities or as the Board otherwise considers necessary,

and so that the Board may impose any limits or restrictions and make any arrangements which it considers necessary or appropriate to deal with treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or under the laws of, any territory or any other matter,

such authorities to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 18 February 2023) but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the authority had not ended.

19. To authorise the Board, in addition to any authority granted pursuant to resolution 18, generally and unconditionally pursuant to section 551 of the Companies Act 2006 to allot shares in the Company and to grant rights to subscribe for or convert any security into shares in the Company up to an aggregate nominal amount of £5,655,084 in relation to any issue by the Company of any Additional Tier 1 instruments ("AT1 Securities") that automatically convert into or are exchanged for ordinary shares in the Company in prescribed circumstances, where the Directors consider that the issue of such AT1 Securities would be desirable, including for the purpose of complying with, or maintaining compliance with, the regulatory requirements or targets applicable to the Company and its subsidiaries and subsidiary undertakings from time to time and otherwise on terms as may be determined by the Directors, such authority to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 18 February 2023) but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the authority had not expired.

20. That:

(a) the Close Brothers Group plc Sharesave Plan 2021 (the "2021 Sharesave"), summarised in Appendix 2 to this Notice, and the rules of which are produced to this Annual General Meeting and for the purposes of identification initialled by the Chairman, be approved and the Board be authorised to do all such acts and things as it considers necessary or desirable to establish the 2021 Sharesave; and

(b) the Board be authorised to adopt further plans based on the 2021 Sharesave but modified to take account of local tax, exchange control or securities laws in overseas territories, provided that any shares made available under such further plans are treated as counting against any limits on individual or overall participation in the 2021 Sharesave.

 

Special resolutions

 

21. That, if resolution 18 granting authority to allot shares is passed, the Board be given power to allot equity securities (as defined in the Companies Act 2006) for cash under the authority given by that resolution and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Companies Act 2006 did not apply to any such allotment or sale, such power to be limited to:

(a) the allotment of equity securities and sale of treasury shares in connection with an offer of, or invitation to apply for, equity securities (but in the case of the authority granted under paragraph (b) of resolution 18, by way of a rights issue only):

1. to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and

2. to holders of other equity securities, as required by the rights of those securities, or as the Board otherwise considers necessary,

and so that the Board may impose any limits or restrictions and make any arrangements which it considers necessary or appropriate to deal with treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or under the laws of, any territory or any other matter; and

(b) in the case of authority granted under paragraph (a) of resolution 18 and/or in the case of any sale of treasury shares, the allotment of equity securities or sale of treasury shares (otherwise than under paragraph (a) above) up to a nominal amount of £1,885,028,

such power to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 18 February 2023) but, in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the power had not ended.

22. That, if resolution 18 granting authority to allot shares is passed, the Board be given the power in addition to any power granted under resolution 21 to allot equity securities (as defined in the Companies Act 2006) for cash under the authority given by that resolution and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Companies Act 2006 did not apply to any such allotment or sale, such power to be:

(a) limited to the allotment of equity securities or sale of treasury shares up to a nominal amount of £1,885,028; and

(b) used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the Board determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice,

such power to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 18 February 2023) but, in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the power had not ended.

23. That, if resolution 19 granting authority to allot AT1 Securities is passed, the Board be given the power, in addition to any powers granted pursuant to resolutions 21 and 22, to allot equity securities (as defined in section 560 of the Companies Act 2006) for cash under the authority given by resolution 19 up to an aggregate nominal amount of £5,655,084 in relation to the issue of AT1 Securities as if section 561 of the Companies Act 2006 did not apply to any such allotment or sale, such power to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 18 February 2023) but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after the power ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the power had not ended.

24. That the Company be authorised for the purposes of section 701 of the Companies Act 2006 to make one or more market purchases (as defined in section 693(4) of the Companies Act 2006) of its ordinary shares of 25p each, such power to be limited:

(a) to a maximum number of 15,080,224 ordinary shares;

(b) by the condition that the minimum price which may be paid for an ordinary share is the nominal amount of that share and the maximum price which may be paid for each ordinary share is the highest of:

(1) an amount equal to 5% above the average market value of an ordinary share for the five business days immediately preceding the day on which that ordinary share is contracted to be purchased; and

(2) the higher of the price of the last independent trade and the highest current independent purchase bid on the London Stock Exchange Trading System,

in each case, exclusive of expenses,

such authority to apply until the conclusion of the next annual general meeting of the Company (or, if earlier, until the close of business on 18 February 2023) but during this period the Company may enter into a contract to purchase ordinary shares which will or may be completed or executed wholly or partly after the authority ends and the Company may purchase ordinary shares pursuant to any such contract as if the authority had not ended.

25. That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.

 

Resolution with voting threshold specified in the Notice of Meeting

 

26. To authorise the Company and its subsidiaries (the "Group") to apply a ratio in relation to the fixed and variable components of remuneration for certain Directors and employees of the Company and the Group's Banking division whose professional activities have a material impact on the risk profile of the Group, so that the variable component of total remuneration for such an individual may exceed 100% of the fixed component of the total remuneration for that individual, provided that such variable component does not exceed 200% of such fixed component.

 

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ over 3,700 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

 

Helen Thorpe

Head of Secretariat

Close Brothers Group plc

 

LEI code: 213800W73SYHR14I3X91

18 November 2021

07725 216541

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGPGBAGUPGGCR
Date   Source Headline
12th Jul 202111:26 amRNSTransaction in Own Shares
9th Jul 20217:00 amRNSDirectorate Change
6th Jul 20214:21 pmRNSDirector/PDMR Shareholding
30th Jun 20219:51 amRNSTotal Voting Rights
28th Jun 202112:57 pmRNSTransaction in Own Shares
22nd Jun 20212:47 pmRNSNotice of Pre-Close Trading Update
21st Jun 20212:00 pmRNSTransaction in Own Shares
15th Jun 20217:00 amRNSPresentation to Analysts and Investors
14th Jun 20215:05 pmRNSDirector/PDMR Shareholding
14th Jun 20212:00 pmRNSTransaction in Own Shares
9th Jun 202112:23 pmRNSResult of Tender Offer
9th Jun 20219:14 amRNSDirector/PDMR Shareholding
8th Jun 20212:52 pmRNSPublication of a Prospectus
7th Jun 20212:35 pmRNSTransaction in Own Shares
1st Jun 20214:41 pmRNSTransaction in Own Shares
1st Jun 202110:46 amRNSTender Offer
28th May 20212:13 pmRNSTotal Voting Rights
21st May 20217:00 amRNSScheduled Trading Update
20th May 202112:00 pmRNSDirector Declaration
17th May 202111:35 amRNSTransaction in Own Shares
10th May 20212:00 pmRNSTransaction in Own Shares
6th May 202112:21 pmRNSDirector/PDMR Shareholding
4th May 20218:59 amRNSTotal Voting Rights
29th Apr 202111:34 amRNSDirector/PDMR Shareholding
26th Apr 202111:09 amRNSTransaction in Own Shares
22nd Apr 20212:41 pmRNSNotice of Quarterly Trading Update
19th Apr 202112:49 pmRNSTransaction in Own Shares
12th Apr 20213:07 pmRNSTransaction in Own Shares
7th Apr 202111:02 amRNSDirector/PDMR Shareholding
6th Apr 20212:00 pmRNSTransaction in Own Shares
31st Mar 20213:34 pmRNSTotal Voting Rights
29th Mar 20212:00 pmRNSTransaction in Own Shares
24th Mar 20214:40 pmRNSDirector/PDMR Shareholding
22nd Mar 202111:20 amRNSTransaction in Own Shares
16th Mar 20217:00 amRNSHalf-year Report
15th Mar 202110:27 amRNSTransaction in Own Shares
8th Mar 20212:12 pmRNSDirector/PDMR Shareholding
8th Mar 20211:57 pmRNSTransaction in Own Shares
1st Mar 202111:37 amRNSTransaction in Own Shares
26th Feb 20211:38 pmRNSTotal Voting Rights
22nd Feb 202111:37 amRNSTransaction in Own Shares
15th Feb 202110:38 amRNSTransaction in Own Shares
15th Feb 20217:00 amRNSBoard committee changes
8th Feb 20212:53 pmRNSDirector/PDMR Shareholding
8th Feb 202111:28 amRNSTransaction in Own Shares
3rd Feb 20213:04 pmRNSHolding(s) in Company
1st Feb 202110:46 amRNSTransaction in Own Shares
29th Jan 20213:09 pmRNSTotal Voting Rights
25th Jan 20219:33 amRNSTransaction in Own Shares
21st Jan 20217:00 amRNSScheduled Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.